首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick ? filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children
【24h】

Performance of an immunofiltration assay detecting IgM antibodies against ZEBRA and viral capsid p18 proteins (Immunoquick ? filtration EBV M) for the diagnosis of heterophile antibody-negative primary Epstein-Barr virus infection in children

机译:免疫过滤试验检测针对ZEBRA和病毒衣壳p18蛋白的IgM抗体(Immunoquick®过滤EBV M)在诊断儿童嗜异性抗体阴性原发性爱泼斯坦-巴尔病毒中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

To the editor.The detection of heterophile antibodies (HA) allows for a rapid and reliable diagnosis of primary Epstein-Barr virus (EBV) infection. Nevertheless, HA are frequently absent in young children.We previously evaluated the performance of an immunofiltration assay (IMFA) detecting IgM antibodies to EBV ZEBRA (BamHl Z EBV replication activator) protein (Immunoquick~R filtration EBV M assay; BioSynex Immunodiagnostic, Strasbourg Cedex, France) for the diagnosis of acute EBV infectious mononu-cleosis (IM). Overall, the sensitivity and the specificity of the assay were found to be 92.5%, and 97.3%, respectively. In the current study we evaluated the performance of this IMFA assay for the diagnosis of HA-negative primary EBV infection in previously healthy children.
机译:对亲本抗体的检测可以快速,可靠地诊断原发性爱泼斯坦-巴尔病毒(EBV)感染。尽管如此,HA经常在幼儿中缺失。我们之前评估了免疫过滤测定法(IMFA)检测EBV ZEBRA(BamH1 Z EBV复制激活剂)蛋白的IgM抗体的性能(Immunoquick〜R过滤EBV M测定法; BioSynex免疫诊断,Strasbourg Cedex (法国),以诊断急性EBV感染性单核细胞增多症(IM)。总体而言,该测定的灵敏度和特异性分别为92.5%和97.3%。在当前的研究中,我们评估了该IMFA测定法对先前健康儿童中HA阴性原发性EBV感染的诊断性能。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号